MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Clinical trials for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat HER2+ cancers
Disease control Recruiting nowThis study compares the drug neratinib alone versus neratinib plus palbociclib in people with HER2-positive gynecologic and other solid tumors (excluding breast cancer). Both drugs block signals that make cancer cells grow. The goal is to see if the combination shrinks tumors or …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:10 UTC
-
Promising drug combo targets recurrent gynecologic cancers
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancer (like ovarian, uterine, or cervical) has returned. The goal is to find the safest dose and see if the combination can shrink tumors. About 24 participants wi…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:08 UTC
-
Can a hormone cream ease Radiation's vaginal side effects?
Symptom relief Recruiting nowThis study tests whether a vaginal DHEA cream can help women who have had radiation for gynecologic, anal, or rectal cancer. Radiation often causes vaginal dryness, burning, and pain. The trial will enroll 25 women to see if the cream is safe and tolerable, and if it improves vag…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 07:08 UTC
-
Remote coaching may ease pain and anxiety after gynecologic surgery
Symptom relief Recruiting nowThis study tests two different remote support programs to see which one helps women feel better after surgery for suspected gynecological cancer. About 160 women will take part, and researchers will measure pain, mood, and sleep. The goal is to find the best way to improve recove…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 26, 2026 07:08 UTC
-
Seaweed extract tested to fight chemo fatigue
Symptom relief Recruiting nowThis study tests whether fucoidan, a supplement from brown seaweed, can reduce fatigue caused by chemotherapy in people with gastrointestinal or gynecological cancer. About 34 participants will take either fucoidan or a placebo for 16 weeks and report their fatigue levels. The go…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 06:52 UTC
-
Which painkiller works best after gynecologic cancer surgery? new study aims to find out
Symptom relief Recruiting nowThis study compares two pain medicines—methadone given through an IV and hydromorphone injected near the spine—for women having surgery for gynecologic cancer. About 140 participants will report their pain levels to see which drug provides better relief. The goal is to improve co…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Home workouts may ease cancer After-Effects
Symptom relief Recruiting nowThis study tests whether a personalized online exercise program can help gynecologic cancer survivors manage symptoms like pain, fatigue, sleep problems, and memory issues. About 40 women who have finished cancer treatment will try the program from home. The goal is to see if it'…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC
-
Genetic matchmaking for cancer: ComboMATCH trial aims to personalize therapy
Knowledge-focused Recruiting nowThis study screens people with advanced solid tumors to see if their cancer has specific genetic changes. Based on those results, they may be matched to a treatment trial that targets their tumor's unique genetics. The goal is to learn how well these targeted combinations work an…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 07:03 UTC
-
Can frailty predict cancer recovery? new study seeks answers
Knowledge-focused Recruiting nowThis study follows 500 adults with newly diagnosed gynecologic cancer to understand how frailty—being more vulnerable to stress from illness—affects their recovery and quality of life. Researchers will measure physical signs like weight loss, weakness, and slow walking. No new tr…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Are surgeons following guidelines to prevent deadly clots in cancer patients?
Knowledge-focused Recruiting nowThis study surveys 500 surgeons and advanced practice providers to see how often they prescribe blood clot prevention medication after abdominal or pelvic cancer surgery. The goal is to understand current practices and improve adherence to guidelines. No patients receive treatmen…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Can genetic testing in ethnic populations unlock better cancer screening?
Knowledge-focused Recruiting nowThis study aims to learn more about cancer genes in people from different ethnic backgrounds. Researchers will test 1,800 adults with various solid tumors to see how common certain gene changes are. The goal is to improve cancer risk assessment and tailor screening for these popu…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 18, 2026 12:06 UTC